Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis

Cancer Letters

Volumn 361, Issue 1, 2015, Pages 57-66

  Hao, Ning Bo ^a   Tang, Bo ^a   Wang, Guo Zheng ^a   Xie, Rui ^a   Hu, Chang Jiang ^a   Wang, Su Min ^a   Wu, Yu Yun ^a   Liu, En ^a   Xie, Xia ^a   Yang, Shi Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Heparanase; HGF; NF B; PI3K Akt

Indexed keywords

HEPARANASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR RELA; BETA GLUCURONIDASE; LUCIFERASE;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GASTRIC CANCER CELL LINE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR INVASION; UPREGULATION; CELL MOTION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; STOMACH; STOMACH NEOPLASMS; SURVIVAL RATE; TRANSCRIPTION INITIATION; TUMOR CELL CULTURE; WESTERN BLOTTING; WOUND HEALING;

BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONIDASE; HEPATOCYTE GROWTH FACTOR; HUMANS; LUCIFERASES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STOMACH; STOMACH NEOPLASMS; SURVIVAL RATE; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED; UP-REGULATION; WOUND HEALING;

EID: 84925270011     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.02.043     Document Type: Article

References (44)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin 2011, 61:69-90.
2. Gupta G.P., Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
3. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol 2006, 7:131-142.
4. Alizadeh A.M., Shiri S., Farsinejad S. Metastasis review: from bench to bedside. Tumour Biol 2014, 35:8483-8523.
5. Davies K.J. The complex interaction of matrix metalloproteinases in the migration of cancer cells through breast tissue stroma. Int. J. Breast Cancer 2014, 2014. 839094.
6. Zhang X., Xu S., Tan Q., Liu L. High expression of heparanase-2 is an independent prognostic parameter for favorable survival in gastric cancer patients. Cancer Epidemiol 2013, 37:1010-1013.
7. Xiong Z., Lu M.H., Fan Y.H., Cao Y.L., Hu C.J., Wu Y.Y., et al. Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo. Int. J. Oncol 2012, 40:1601-1609.
8. Levy-Adam F., Ilan N., Vlodavsky I. Tumorigenic and adhesive properties of heparanase. Semin. Cancer Biol 2010, 20:153-160.
9. Wegrowski Y., Maquart F.X. Involvement of stromal proteoglycans in tumour progression. Crit. Rev. Oncol. Hematol 2004, 49:259-268.
10. Ostapoff K.T., Awasthi N., Cenik B.K., Hinz S., Dredge K., Schwarz R.E., et al. PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancer. Mol. Cancer Ther 2013, 12:1190-1201.
11. Elkin M., Ilan N., Ishai-Michaeli R., Friedmann Y., Papo O., Pecker I., et al. Heparanase as mediator of angiogenesis: mode of action. FASEB J. 2001, 15:1661-1663.
12. Vlodavsky I., Miao H.Q., Medalion B., Danagher P., Ron D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 1996, 15:177-186.
13. Sanderson R.D., Yang Y. Syndecan-1: a dynamic regulator of the myeloma microenvironment. Clin. Exp. Metastasis 2008, 25:149-159.
14. Ilan N., Elkin M., Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int. J. Biochem. Cell Biol 2006, 38:2018-2039.
15. de Mestre A.M., Rao S., Hornby J.R., Soe-Htwe T., Khachigian L.M., Hulett M.D. Early growth response gene 1 (EGR1) regulates heparanase gene transcription in tumor cells. J. Biol. Chem 2005, 280:35136-35147.
16. Jiang P., Kumar A., Parrillo J.E., Dempsey L.A., Platt J.L., Prinz R.A., et al. Cloning and characterization of the human heparanase-1 (HPR1) gene promoter: role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity. J. Biol. Chem 2002, 277:8989-8998.
17. Lu W.C., Liu Y.N., Kang B.B., Chen J.H. Trans-activation of heparanase promoter by ETS transcription factors. Oncogene 2003, 22:919-923.
18. Meirovitz A., Goldberg R., Binder A., Rubinstein A.M., Hermano E., Elkin M. Heparanase in inflammation and inflammation-associated cancer. FEBS J. 2013, 280:2307-2319.
19. Rao G., Liu D., Xing M., Tauler J., Prinz R.A., Xu X. Induction of heparanase-1 expression by mutant B-Raf kinase: role of GA binding protein in heparanase-1 promoter activation. Neoplasia 2010, 12:946-956.
20. Wang G.Z., Tang X.D., Lu M.H., Gao J.H., Liang G.P., Li N., et al. Multiple antigenic peptides of human heparanase elicit a much more potent immune response against tumors. Cancer Prev. Res. (Phila.) 2011, 4:1285-1295.
21. Tang X.D., Wang G.Z., Guo J., Lu M.H., Li C., Li N., et al. Multiple antigenic peptides based on H-2K(b)-restricted CTL epitopes from murine heparanase induce a potent antitumor immune response in vivo. Mol. Cancer Ther 2012, 11:1183-1192.
22. Tang X.D., Guo S.L., Wang G.Z., Li N., Wu Y.Y., Fang D.C., et al. In vitro and ex vivo evaluation of a multi-epitope heparinase vaccine for various malignancies. Cancer Sci 2014, 105:9-17.
23. Li Y., Huang X., Zhong W., Zhang J., Ma K. Ganglioside GM3 promotes HGF-stimulated motility of murine hepatoma cell through enhanced phosphorylationof cMet at specific tyrosine sites and PI3K/Akt-mediatedmigration signaling. Mol. Cell. Biochem 2013, 382:83-92.
24. Takeda S., Liu H., Sasagawa S., Dong Y., Trainor P.A., Cheng E.H., et al. HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma. J. Clin. Invest 2013, 123:3154-3165.
25. Wang K., Zhuang Y., Liu C., Li Y. Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling. Arch. Biochem. Biophys 2012, 526:38-43.
26. Garnett J., Chumbalkar V., Vaillant B., Gururaj A.E., Hill K.S., Latha K., et al. Regulation of HGF expression by DeltaEGFR-mediated c-Met activation in glioblastoma cells. Neoplasia 2013, 15:73-84.
27. Sipeki S., Bander E., Buday L., Farkas G., Bacsy E., Ways D.K., et al. Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering. Cell. Signal 1999, 11:885-890.
28. Esencay M., Newcomb E.W., Zagzag D. HGF upregulates CXCR4 expression in gliomas via NF-kappaB: implications for glioma cell migration. J. Neurooncol 2010, 99:33-40.
29. Cai Y.G., Fang D.C., Chen L., Tang X.D., Chen T., Yu S.T., et al. Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro. Tumour Biol 2007, 28:238-246.
30. Hu C., Liu D., Zhang Y., Lou G., Huang G., Chen B., et al. LXRalpha-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells. Oncogene 2014, 33:2888-2897.
31. Zhang Y., Farenholtz K.E., Yang Y., Guessous F., Dipierro C.G., Calvert V.S., et al. Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition. Clin. Cancer Res 2013, 19:1433-1444.
32. Ramani V.C., Yang Y., Ren Y., Nan L., Sanderson R.D. Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity. J. Biol. Chem 2011, 286:6490-6499.
33. Dong G., Chen Z., Li Z.Y., Yeh N.T., Bancroft C.C., Van Waes C. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res 2001, 61:5911-5918.
34. Boccaccio C., Comoglio P.M. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat. Rev. Cancer 2006, 6:637-645.
35. Bussolino F., Di Renzo M.F., Ziche M., Bocchietto E., Olivero M., Naldini L., et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol 1992, 119:629-641.
36. Cao R., Bjorndahl M.A., Gallego M.I., Chen S., Religa P., Hansen A.J., et al. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood 2006, 107:3531-3536.
37. Toiyama Y., Yasuda H., Saigusa S., Matushita K., Fujikawa H., Tanaka K., et al. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer. Int. J. Cancer 2012, 130:2912-2921.
38. Zhang Y.W., Wang L.M., Jove R., Vande Woude G.F. Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis. Oncogene 2002, 21:217-226.
39. Trusolino L., Bertotti A., Comoglio P.M. MET signalling: principles and functions in development, organ regeneration and cancer. Nat. Rev. Mol. Cell Biol 2010, 11:834-848.
40. Huo X., Zhang X., Yu C., Zhang Q., Cheng E., Wang D.H., et al. In oesophageal squamous cells exposed to acidic bile salt medium, omeprazole inhibits IL-8 expression through effects on nuclear factor-kappaB and activator protein-1. Gut 2014, 63:1042-1052.
41. Murshed F., Farhana L., Dawson M.I., Fontana J.A. NF-kappaB p65 recruited SHP regulates PDCD5-mediated apoptosis in cancer cells. Apoptosis 2014, 19:506-517.
42. Yang Y., Macleod V., Miao H.Q., Theus A., Zhan F., Shaughnessy J.D., et al. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis. J. Biol. Chem 2007, 282:13326-13333.
43. Fux L., Feibish N., Cohen-Kaplan V., Gingis-Velitski S., Feld S., Geffen C., et al. Structure-function approach identifies a COOH-terminal domain that mediates heparanase signaling. Cancer Res 2009, 69:1758-1767.
44. Wu X., Chen X., Zhou Q., Li P., Yu B., Li J., et al. Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer. Cancer Lett 2013, 335:128-135.